Pankaj Kumar Singh

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Reactive Oxygen Species

Epithelial Mesenchymal Transition

Top Venues

ACS pharmacology & translational science

Expert opinion on drug metabolism & toxicology

Journal of medicinal chemistry

University of Sassari

Punjabi University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sassari Feb 09 2019

Italy

Research Collaborator :: Department of Chemistry and Pharmacy

Education History

Punjabi University Sep 17 2015 - Dec 28 2018

India

PHD :: Department of Pharmaceutical Sciences and Research

Publications

Himanshu Verma, Gera Narendra, Baddipadige Raju, Pankaj Kumar Singh, Om Silakari
Dihydropyrimidine Dehydrogenase-Mediated Resistance to 5-Fluorouracil: Mechanistic Investigation and Solution. ACS pharmacology & translational science 5 (11) (2022)
Ravi Ranjan Kumar, Bhaskar Sahu, Shelly Pathania, Pankaj Kumar Singh, Md Jawaid Akhtar, Bhupinder Kumar
Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure-Activity Relationships. ChemMedChem 16 (12) (2021)
Shelly Pathania, Pankaj Kumar Singh
Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols? Expert opinion on drug metabolism & toxicology 17 (4) (2020)
Shuai Hu, Mario Sechi, Pankaj Kumar Singh, Lipeng Dai, Sean McCann, Duxin Sun, Mats Ljungman, Nouri Neamati
A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species. Journal of medicinal chemistry 63 (17) (2020)